OPEN END TURBO OPTIONSSCHEIN LONG - STRYKER CORP. Stock

Certificat

DE000GK8GHY4

Market Closed - BOERSE MUENCHEN 14:25:23 2024-05-24 EDT
10.28 EUR +3.94% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - STRYKER CORP.
Current month-3.47%
1 month-4.19%
Date Price Change
24-05-24 10.28 +3.94%
24-05-23 9.89 -3.61%
24-05-22 10.26 +5.88%
24-05-21 9.69 -0.82%
24-05-20 9.77 -1.91%

Real-time BOERSE MUENCHEN

Last update May 24, 2024 at 02:25 pm

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Goldman Sachs
WKN GK8GHY
ISINDE000GK8GHY4
Date issued 2022-07-29
Strike 224.8 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.31
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 12.87
Lowest since issue 0.71
Spread 0.07
Spread %0.68%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
335.5 USD
Average target price
372.4 USD
Spread / Average Target
+10.97%
Consensus